Discovery of Novel Markers for Identifying Cognitive Decline Using Neuron-Derived Exosomes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of Novel Markers for Identifying Cognitive Decline Using Neuron-Derived Exosomes
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-31
DOI
10.3389/fnagi.2021.696944
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement-Mediated Events in Alzheimer’s Disease: Mechanisms and Potential Therapeutic Targets
- (2020) Andrea J. Tenner JOURNAL OF IMMUNOLOGY
- Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease
- (2019) Luke S. Watson et al. Molecular Neurodegeneration
- Exosomes regulate neurogenesis and circuit assembly
- (2019) Pranav Sharma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene-by-environment interactions in Alzheimer’s disease and Parkinson’s disease
- (2019) Amy R. Dunn et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Diagnosis and Management of Dementia: Review
- (2019) Zoe Arvanitakis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The ProteomeXchange consortium in 2020: enabling ‘big data’ approaches in proteomics
- (2019) Eric W Deutsch et al. NUCLEIC ACIDS RESEARCH
- Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer’s disease
- (2018) Edward J. Goetzl et al. FASEB JOURNAL
- Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
- (2018) Ross W. Paterson et al. Alzheimers Research & Therapy
- Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer’s disease dementia from normal controls: preliminary findings
- (2018) Marwan N Sabbagh et al. BMC Neurology
- Gene Expression Profiling of Peripheral Blood Leukocytes Shows Consistent Longitudinal Downregulation of TOMM40 and Upregulation of KIR2DL5A, PLOD1, and SLC2A8 Among Fast Progressors in Early Alzheimer's Disease
- (2018) Mei Sian Chong et al. JOURNAL OF ALZHEIMERS DISEASE
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Heterogeneity of Alzheimer’s disease: consequence for drug trials?
- (2018) Gayatri Devi et al. Alzheimers Research & Therapy
- Complement C7 is a novel risk gene for Alzheimer's disease in Han Chinese
- (2018) Deng-Feng Zhang et al. National Science Review
- Alzheimer's disease
- (2017) C. A. Lane et al. EUROPEAN JOURNAL OF NEUROLOGY
- Time-course global proteome analyses reveal an inverse correlation between Aβ burden and immunoglobulin M levels in the APPNL-F mouse model of Alzheimer disease
- (2017) Hansen Wang et al. PLoS One
- Expectant futures and an early diagnosis of Alzheimer's disease: Knowing and its consequences
- (2017) Julia Swallow SOCIAL SCIENCE & MEDICINE
- Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease
- (2016) Edward J. Goetzl et al. FASEB JOURNAL
- Antigen Presentation to B Cells
- (2016) Balthasar A. Heesters et al. TRENDS IN IMMUNOLOGY
- Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage
- (2015) Liming Shen et al. Journal of Proteomics
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Exosomes: Novel Biomarkers for Clinical Diagnosis
- (2015) Jin Lin et al. TheScientificWorldJOURNAL
- Exosomes: Novel Biomarkers for Clinical Diagnosis
- (2015) Jin Lin et al. Scientific World Journal
- Future directions in Alzheimer's disease from risk factors to prevention
- (2014) Bushra Imtiaz et al. BIOCHEMICAL PHARMACOLOGY
- The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease
- (2014) Jie Liu et al. Channels
- Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms
- (2013) D. Ricklin et al. JOURNAL OF IMMUNOLOGY
- Zyxin is a novel target for beta-amyloid peptide: characterization of its role in Alzheimer's pathogenesis
- (2013) Cristina Lanni et al. JOURNAL OF NEUROCHEMISTRY
- Autoantibodies: Double Agents in Human Disease
- (2013) N. K. Acharya et al. Science Translational Medicine
- Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals
- (2012) Fei Song et al. PLoS One
- Mild Cognitive Impairment in Older Adults
- (2012) Yonas E. Geda Current Psychiatry Reports
- Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases?
- (2012) Shayne A. Bellingham et al. Frontiers in Physiology
- Zyxin Is a Critical Regulator of the Apoptotic HIPK2-p53 Signaling Axis
- (2011) J. Crone et al. CANCER RESEARCH
- It's All About Change: The Antigen-driven Initiation of B-Cell Receptor Signaling
- (2010) W. Liu et al. Cold Spring Harbor Perspectives in Biology
- Zyxin is a novel interacting partner for SIRT1
- (2009) Yuki Fujita et al. BMC CELL BIOLOGY
- Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
- (2009) Shannon Risacher et al. Current Alzheimer Research
- Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism
- (2009) D. Allan Butterfield et al. JOURNAL OF NEUROCHEMISTRY
- C4b-binding protein in Alzheimer's disease: Binding to Aβ1–42 and to dead cells
- (2008) Leendert. A. Trouw et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation